No sign of Rotavirus co-infection in COVID-19 patients with gastrointestinal symptoms.

IF 1.2 4区医学 Q4 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

Malawi Medical Journal Pub Date : 2023-03-01 DOI:10.4314/mmj.v35i1.6

Milad Zandi, Saber Soltani, Riam Sadooni, Shokrollah Salmanzadeh, Yousef Erfani, Ramin Shahbahrami, Maghsud Piri, Reza Pakzad, Nasrin Ghodratifard, Alireza Eftekhari Moghadam, Samaneh Abbasi

{"title":"No sign of Rotavirus co-infection in COVID-19 patients with gastrointestinal symptoms.","authors":"Milad Zandi, Saber Soltani, Riam Sadooni, Shokrollah Salmanzadeh, Yousef Erfani, Ramin Shahbahrami, Maghsud Piri, Reza Pakzad, Nasrin Ghodratifard, Alireza Eftekhari Moghadam, Samaneh Abbasi","doi":"10.4314/mmj.v35i1.6","DOIUrl":null,"url":null,"abstract":"Background and aims: The main goal of the present study is to investigate the incidence of Rotavirus co-infection in COVID-19 patients.Methods and results: Fecal samples of COVID-19 patients with gastrointestinal symptoms which had positive PCR- were collected from Abadan's hospital, Iran during the period December 2020 to January 2021. Samples were analyzed by RT-PCR to determine the presence of Rotavirus. Finally, the total samples size of 37 were included in this study. The mean age of patients was 48.22 years. Abdominal pain alone was detected in 48.65% of the patients. At least one gastrointestinal symptom was detected in all of the patients. Diarrhea and fever were seen in 13.51% and 59.46% of patients, respectively. Nausea and vomiting were seen in 5.41% of the patients. RT-PCR showed no infection of Rotavirus among the patients.Conclusion: Gastrointestinal symptoms related to COVID-19 are common. More studies is need among these patients groups for investigate co-infection with other fecal viral shedding carries, due to a worse prognosis and its association with disease severity.","PeriodicalId":18185,"journal":{"name":"Malawi Medical Journal","volume":null,"pages":null},"PeriodicalIF":1.2000,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645899/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Malawi Medical Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4314/mmj.v35i1.6","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}

引用次数: 0

Abstract

Background and aims: The main goal of the present study is to investigate the incidence of Rotavirus co-infection in COVID-19 patients.

Methods and results: Fecal samples of COVID-19 patients with gastrointestinal symptoms which had positive PCR- were collected from Abadan's hospital, Iran during the period December 2020 to January 2021. Samples were analyzed by RT-PCR to determine the presence of Rotavirus. Finally, the total samples size of 37 were included in this study. The mean age of patients was 48.22 years. Abdominal pain alone was detected in 48.65% of the patients. At least one gastrointestinal symptom was detected in all of the patients. Diarrhea and fever were seen in 13.51% and 59.46% of patients, respectively. Nausea and vomiting were seen in 5.41% of the patients. RT-PCR showed no infection of Rotavirus among the patients.

Conclusion: Gastrointestinal symptoms related to COVID-19 are common. More studies is need among these patients groups for investigate co-infection with other fecal viral shedding carries, due to a worse prognosis and its association with disease severity.

查看原文本刊更多论文

有胃肠道症状的COVID-19患者无轮状病毒合并感染迹象

背景与目的本研究的主要目的是调查COVID-19患者轮状病毒合并感染的发生率。方法与结果收集2020年12月至2021年1月在伊朗阿巴丹医院采集的2019冠状病毒病胃肠道症状PCR阳性患者粪便样本。采用RT-PCR对样本进行分析，以确定是否存在轮状病毒。最终纳入本研究的总样本量为37个。患者平均年龄48.22岁。48.65%的患者仅出现腹痛。所有患者均至少有一种胃肠道症状。腹泻和发热分别占13.51%和59.46%。恶心、呕吐发生率为5.41%。RT-PCR结果显示患者未感染轮状病毒。结论与COVID-19相关的胃肠道症状较为常见。由于预后较差及其与疾病严重程度的相关性，需要对这些患者群体进行更多的研究，以调查与其他粪便病毒脱落载体的共同感染。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Malawi Medical Journal Medicine-General Medicine

CiteScore

1.50

自引率

0.00%

发文量

审稿时长

>12 weeks

期刊介绍： Driven and guided by the priorities articulated in the Malawi National Health Research Agenda, the Malawi Medical Journal publishes original research, short reports, case reports, viewpoints, insightful editorials and commentaries that are of high quality, informative and applicable to the Malawian and sub-Saharan Africa regions. Our particular interest is to publish evidence-based research that impacts and informs national health policies and medical practice in Malawi and the broader region. Topics covered in the journal include, but are not limited to: - Communicable diseases (HIV and AIDS, Malaria, TB, etc.) - Non-communicable diseases (Cardiovascular diseases, cancer, diabetes, etc.) - Sexual and Reproductive Health (Adolescent health, education, pregnancy and abortion, STDs and HIV and AIDS, etc.) - Mental health - Environmental health - Nutrition - Health systems and health policy (Leadership, ethics, and governance) - Community systems strengthening research - Injury, trauma, and surgical disorders